La mayoría de los pacientes mantendrían su peso con menos dosis de medicamentos GLP-1news2026-03-06T09:00:04+00:00March 6th, 2026|The New York Times|
Most Patients Keep Weight Off With Fewer GLP-1 Shots, Study Findsnews2026-03-04T20:53:59+00:00March 4th, 2026|The New York Times|
TrumpRx Is Set to Go Live on Thursdaynews2026-02-05T17:33:59+00:00February 5th, 2026|The New York Times|
Novo Nordisk Warns of First Sales Drop Since Start of Ozempicnews2026-02-04T18:48:50+00:00February 4th, 2026|The New York Times|
La ostarina, el fármaco que está en el centro del dopaje deportivonews2026-02-03T10:04:43+00:00February 3rd, 2026|The New York Times|
The Wonder Drug That’s Plaguing Sportsnews2026-02-02T10:00:59+00:00February 2nd, 2026|The New York Times|
Weight-Loss Drugs Could Save U.S. Airlines $580 Million Per Yearnews2026-01-19T16:15:35+00:00January 19th, 2026|The New York Times|
The Truth About Weight-Loss Drugs Like Ozempic: You Probably Need Them Forevernews2026-01-15T16:10:06+00:00January 15th, 2026|The New York Times|
Joel Habener, Whose Research Led to Weight-Loss Drugs, Dies at 88news2026-01-09T22:54:21+00:00January 9th, 2026|The New York Times|
